Erratum: Enhanced expression of naofen in kidney of streptozotocin-induced diabetic rats: Possible correlation to apoptosis of tubular epithelial cells (Clinical and Experimental Nephrology DOI: 10.1007/s10157-010-0276-1);Enhanced expression of naofen in kidney of streptozotocininduced diabetic rats: Possible correlation to apoptosis of tubular epithelial cells

Clinical and Experimental Nephrology

Volumn 14, Issue 3, 2010, Pages 205-212

  Sato, Yuko ^a   Feng, Guo Gang ^a   Huang, Lei ^a   Fan, Jun Hua ^b   Li, Chang ^c   Ann, Jun ^a   Tsunekawa, Koji ^a   Kurokawa, Shuji ^a   Fujiwara, Yoshihiro ^a   Komatsu, Toru ^a   Kondo, Fumio ^a   Ishikawa, Naohisa ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Heping District Center for Disease Control and Preven   (China)

Author keywords

Apoptosis; Diabetic nephropathy; Hyperglycemia

Indexed keywords

CASPASE 3; GLUCOSE; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; NAOFEN; PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NAOFEN PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; GENE LOCATION; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DYSFUNCTION; KIDNEY EPITHELIUM; KIDNEY TUBULE CELL; MALE; NONHUMAN; PROTEIN LOCALIZATION; RAT; STREPTOZOCIN DIABETES; UPREGULATION; ANIMAL; CELL LINE; EPITHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HYPERGLYCEMIA; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; HYPERGLYCEMIA; KIDNEY; KIDNEY TUBULES; MALE; PROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 77956627992     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0287-y     Document Type: Erratum

References (34)

1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341:1127-1133
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615-1625
4. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med. 2008;233:4-11.
5. Lee SC, Pervaiz S. Apoptosis in the pathophysiology of diabetes mellitus. Int J Biochem Cell Biol. 2007;39:497-504.
6. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006;13, 1423-1433
7. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem. 2005;16:705-713
8. Nakao H, Takeda T. Escherichia coli Shiga toxin. J Nat Toxins. 2000;9:299-313.
9. Taguchi T, Uchida H, Kiyokawa N, Mori T, Sato N, Horie H, et al. Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int. 1998;53:1681-1688
10. Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T. Activation of beta(2)-adrenoceptor prevents shiga toxin 2-induced TNF-alpha gene transcription. J Am Soc Nephrol. 2001;12:2288-2299
11. Yoshida T, Fukada M, Koide N, Ikeda H, Sugiyama T, Kato Y, et al. Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. J Infect Dis. 1999;180:2048-2052
12. An J, Feng GG, Huang L, Kurokawa T, Nonami T, Koide T, et al. Effects of 1-O-hexyl-2,3,5-trimethylhydroquinone on carbon tetrachloride-induced hepatic cirrhosis in rats. Hepatol Res (in press).
13. Feng GG, Yamada M, Wongsawatkul O, Li C, Huang L, An J, et al. Role of naofen, a novel WD repeat-containing protein, in reducing nitric oxide-induced relaxation. Clin Exp Pharmacol Physiol. 2008;35:1447-1453
14. 1A receptor antagonist pyrapyridolol against postischemic guineapig myocardial dysfunction and apoptosis through the mitochondrial permeability transition pore. Eur J Pharmacol. 2006;534, 165-177
15. Thomas GL, Yang B, Wagner BE, Savill J, El Nahas AM. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant. 1998;13:2216-2226
16. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy Curr Diabetes Rev. 2008 4 39-45.
17. Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli Diabetologia. 1999 42 878-886
18. DiPetrillo K, Gesek FA. Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats. Am J Nephrol. 2004;24:352-359
19. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 1993;42:450-456 (Pubitemid 23066522)
20. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med. 1997;45:50-56
21. Kumar D, Zimpelmann J, Robertson S, Burns KD. Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney. Nephron Exp Nephrol. 2004;96:77-88.
22. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A. Apoptosis in glomerular sclerosis. Kidney Int. 1996;49:103-111
23. Savill J. Regulation of glomerular cell number by apoptosis. Kidney Int. 1999;56:1216-1222
24. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhaüsl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes. 1995;44:1323-1327
25. Khera T, Martin J, Riley S, Steadman R, Phillips AO. Glucose enhances mesangial cell apoptosis. Lab Invest. 2006;86:566-577
26. Ishii N, Ogawa Z, Suzuki K, Numakami K, Saruta T, Itoh H. Glucose loading induces DNA fragmentation in rat proximal tubular cells. Metabolism. 1996;45:1348-1353
27. Kang BP, Urbonas A, Baddoo A, Baskin S, Malhotra A, Meggs LG. IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose. Am J Physiol Renal Physiol. 2003;285:1013-1024
28. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Yamasaki K, et al. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. Diabetes. 2002;51:2604-2611
29. Ortiz A. Nephrology forum: apoptotic regulatory proteins in renal injury. Kidney Int. 2000;58:467-485
30. Zhang W, Khanna P, Chan LL, Campbell G, Ansari NH. Diabetes- induced apoptosis in rat kidney. Biochem Mol Med. 1997;61:58-62.
31. Wang W, Tzanidis A, Divjak M, Thomson NM, Stein-Oakley AN. Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol. 2001;12:1422-1433
32. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol. 2002;283:173-180
33. Tunçdemir M, Ozturk M. The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats. J Mol Histol. 2008;39:605-616
34. Rasch R. Tubular lesions in streptozotocin-diabetic rats. Diabetologia. 1984;27:32-37